MedTrace Logo

MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia

NCT03279965 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-09-12

No results posted yet for this study

Summary

This is a small pilot / feasibility study (Approximately 50 patients) to assess the possibility of clinical implementation of MRI assessment of patients with cystic fibrosis and primary ciliary dyskinesia.

Patients will undergo their standard CT imaging and lung function investigations and additionally will undergo MRI examination. Reports from CT (the current gold standard) and MRI will be assessed for concordance and patient acceptability and examination implementation costs will also be assessed. Novel MRI-based potential markers of CF and PCD disease state will also be assessed.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

MRI of lungs, paranasal sinuses and liver in addition to established clinical examinations (lung CT, pulmonary function testing)

Sponsors & Collaborators

  • Bioxydyn Ltd, Manchester

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Anand Devaraj · Royal Brompton Hospital, London

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-05
Primary Completion
2018-05-05
Completion
2018-05-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03279965 on ClinicalTrials.gov